NeedleVue LC1 (ultrasound scanner)

History

2025: Product Announcement

In mid-August 2025, DeepSight Technology introduced an ultra-high-resolution ultrasound scanner for complex surgical interventions, including cancer surgery. The NeedleVue LC1 platform provides accuracy up to 1 mm, while reducing the dose of radiation.

The NeedleVue LC1 is a self-contained trolley system designed for ultrasound diagnostics. It is equipped with an adjustable angle display for viewing medical images. DeepSight Technology claims the new platform provides an opportunity to move beyond traditional imaging by combining ultra-high-resolution ultrasound scanning with smart tool tracking. This allows physicians to precisely monitor actions, navigate complex anatomical structures, and perform interventions with maximum effectiveness.

𝓲

Фото: DeepSight Technology

The NeedleVue LC1 platform can be used for biopsy, malignant tumor ablation, targeted drug delivery, vascular access, and cardiac surgery. The system is also suitable for spinal therapy, neuromodulation, minimally invasive surgery and robotic procedures. With the use of NeedleVue, the risks of surgery are LC1 reduced, which contributes to improved treatment outcomes and reduced patient recovery time. The platform has received approval from the U.S. Food and Drug Administration (FDA).

We have developed next-generation technology to improve ultrasound. The system provides high-definition imaging and improves the effectiveness of medical procedures, "says Nader Sadrzadeh, CEO of DeepSight Technology.[1]

Notes